AAAAAA

   
Results: 1-5 |
Results: 5
THE EFFECT OF INTRAVESICAL MITOMYCIN-C ON RECURRENCE OF NEWLY-DIAGNOSED SUPERFICIAL BLADDER-CANCER - A FURTHER REPORT WITH 7 YEARS OF FOLLOW-UP
Authors: TOLLEY DA PARMAR MKB GRIGOR KM LALLEMAND G BEYNON LL FELLOWS SJ FREEDMAN LS HALL RR HARGREAVE TB MUNSON K NEWLING DWW RICHARDS B ROBINSON MRG ROSE MB SMITH PH WILLIAMS JL WHELAN P
Citation: Da. Tolley et al., THE EFFECT OF INTRAVESICAL MITOMYCIN-C ON RECURRENCE OF NEWLY-DIAGNOSED SUPERFICIAL BLADDER-CANCER - A FURTHER REPORT WITH 7 YEARS OF FOLLOW-UP, The Journal of urology, 155(4), 1996, pp. 1233-1237
THE EFFECT OF INTRAVESICAL MITOMYCIN-C ON RECURRENCE OF NEWLY-DIAGNOSED SUPERFICIAL BLADDER-CANCER - A FURTHER REPORT WITH 7 YEARS OF FOLLOW-UP - REPLY
Authors: TOLLEY DA PARMAR MKB GRIGOR KM LALLEMAND G BEYNON LL FELLOWS SJ FREEDMAN LS HALL RR HARGREAVE TB MUNSON K NEWLING DWW RICHARDS B ROBINSON MRG ROSE MB SMITH PH WILLIAMS JL WHELAN P
Citation: Da. Tolley et al., THE EFFECT OF INTRAVESICAL MITOMYCIN-C ON RECURRENCE OF NEWLY-DIAGNOSED SUPERFICIAL BLADDER-CANCER - A FURTHER REPORT WITH 7 YEARS OF FOLLOW-UP - REPLY, The Journal of urology, 155(4), 1996, pp. 1238-1238
RANDOMIZED TRIAL OF 4-DRUG VS LESS INTENSIVE 2-DRUG CHEMOTHERAPY IN THE PALLIATIVE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)AND POOR-PROGNOSIS (VOL 73, PG 406, 1996)
Authors: BLEEHEN NM GIRLING DJ HOPWOOD P LALLEMAND G MACHIN D STEPHENS RJ BAILEY AJ
Citation: Nm. Bleehen et al., RANDOMIZED TRIAL OF 4-DRUG VS LESS INTENSIVE 2-DRUG CHEMOTHERAPY IN THE PALLIATIVE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)AND POOR-PROGNOSIS (VOL 73, PG 406, 1996), British Journal of Cancer, 74(6), 1996, pp. 997-997
RANDOMIZED TRIAL OF 4-DRUG VS LESS INTENSIVE 2-DRUG CHEMOTHERAPY IN THE PALLIATIVE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)AND POOR-PROGNOSIS
Authors: BLEEHEN NM GIRLING DJ HOPWOOD P LALLEMAND G MACHIN D STEPHENS RJ BAILEY AJ
Citation: Nm. Bleehen et al., RANDOMIZED TRIAL OF 4-DRUG VS LESS INTENSIVE 2-DRUG CHEMOTHERAPY IN THE PALLIATIVE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)AND POOR-PROGNOSIS, British Journal of Cancer, 73(3), 1996, pp. 406-413
THE FEASIBILITY OF USING GLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) TO INCREASE THE PLANNED DOSE INTENSITY OF DOXORUBICIN, CYCLOPHOSPHAMIDE AND ETOPOSIDE (ACE) IN THE TREATMENT OF SMALL-CELL LUNG-CANCER
Authors: THATCHER N ANDERSON H BLEEHEN NI GIRLING DJ LALLEMAND G MACHIN D STEPHENS RJ
Citation: N. Thatcher et al., THE FEASIBILITY OF USING GLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) TO INCREASE THE PLANNED DOSE INTENSITY OF DOXORUBICIN, CYCLOPHOSPHAMIDE AND ETOPOSIDE (ACE) IN THE TREATMENT OF SMALL-CELL LUNG-CANCER, European journal of cancer, 31A(2), 1995, pp. 152-156
Risultati: 1-5 |